Books |
Country Music |
Magazines |
Movies |
Museums |
Music |
News & Talk Shows |
Performing Arts |
Television |
Web Sites
Aftermarket |
Classic Autos |
Consumer Publications |
Motorcycle & Bike |
Racing |
Recreational Vehicle |
Repair & Service |
Trade Publications
Advertising / Marketing |
Books |
e-Commerce |
Finance |
Franchise |
Human Resources |
Insurance |
Investment |
Markets |
Network Marketing |
Public Relations |
Publications |
Real Estate |
Retail |
Stocks |
Supermarkets
Databases |
Games & Entertainment |
Instruction |
Linux / GNU / Open Source |
Operating Systems |
Programming |
Security |
Software |
Utilities
Gifts and Collectibles |
Hobbies |
Web Sites / Internet |
College / University |
Home Schooling |
K-12 |
Post Graduate |
Technical
Education |
Law Enforcement |
Legislative |
Local |
National |
Public Services |
State |
Transportation
Banking / Personal Finance |
Home Furnishings / Interiors |
Parenting |
Wedding / Bridal |
Aerospace / Defense |
Agriculture |
Airlines |
Apparel / Textiles |
Broadcast |
Construction / Building |
Electrical |
Food |
Funeral |
Healthcare |
Leisure / Hospitality |
Logistics / Shipping |
Mining / Metals |
Oil / Energy |
Paper / Forest Products |
Plumbing, Heating & AC |
Print Media |
Publishing |
Radio |
Restaurants |
Tobacco |
Toy
Beauty |
Fashion |
Food / Beverage |
Health & Fitness |
Hotel / Resorts |
Pastimes |
Restaurants |
Retirement |
Travel & Tourism
Alternative Medicine |
Asthma |
Cancer |
Cardiology |
Chiropractic |
Dental |
Dermatology |
Diabetes |
Emergency |
Family Medicine |
General |
Geriatrics |
Hospitals |
Infectious Diseases |
Internal Medicine |
Managed Care / HMO |
Medical Products |
Mental Health |
Neurology |
Nursing |
Nutrition |
OB / GYN |
Pediatrics |
Pharmaceuticals |
Physical Therapy |
Radiology / Imaging |
Research |
Surgery |
Vision
Christian |
Islam |
Jewish |
Other
African American Interests |
Asian Interests |
Children's Issues |
Gay / Lesbian |
Hispanic |
Men's Interests |
Native American |
Senior Citizens |
Social Services |
Teen Issues/Interests |
Women's Interest
Baseball |
Basketball |
Bicycling |
Boating / Maritime |
Bowling |
Boxing |
Fishing |
Football |
Golf |
Hockey |
Hunting |
Martial Arts |
Outdoors |
Rugby |
Soccer |
Water |
Winter / Snow
Biotechnology |
Computer |
Electronics |
Games |
Graphics / Printing / CAD |
Hardware / Peripherals |
Industrial |
Internet |
Multimedia |
Networking |
Public Sector / Government |
Robotics |
Software |
Telecommunications
Press Releases by
|
|
|
Interventional Oncology Market size is set to grow by USD 1.04 bn from 2024-2028, AngioDynamics Inc., Becton Dickinson and Co. & Boston Scientific Corp., and more to emerge as Some of the Key Companies- TechnavioNEW YORK, March 19, 2024 /PRNewswire/ -- The global interventional oncology market size is estimated to grow by USD 1.04 bn from 2024 to 2028, according to Technavio. The market is estimated to grow at a CAGR of 7.7% during the forecast period. As a content expert, I'd be happy to provide... WINNERS ANNOUNCED: UPL CORP LEADS US$1.75M INVESTMENT IN BIOLOGICAL AG-TECH INNOVATORSSOLASTA Bio and Impetus Ag announced as winners of the Radicle Natural Plant Protection (NPP) Challenge by UPL Winners identified from a pool of 237 start-up applicants advancing natural and biological solutions LONDON, March 19, 2024 /PRNewswire/ -- UPL Corporation Ltd. (UPL Corp), a... Tetra Pharm Technologies introduit un analgésique au Royaume-UniLa société biopharmaceutique danoise Tetra Pharm Technologies est fière d'annoncer le lancement de son médicament analgésique sur ordonnance, XATEPA®, au Royaume-Uni. COPENHAGUE, Danemark, 19 mars 2024 /PRNewswire/ -- à la suite du lancement réussi de XATEPA® en Allemagne l'an dernier, le... Tetra Pharm Technologies führt im Vereinigten Königreich ein schmerzlinderndes Medikament einDas dänische biopharmazeutische Unternehmen Tetra Pharm Technologies ist stolz darauf, die Einführung seines verschreibungspflichtigen Schmerzmittels XATEPA® im Vereinigten Königreich bekannt zu geben. KOPENHAGEN, Dänemark, 19. März 2024 /PRNewswire/ -- Nach der erfolgreichen... Tetra Pharm Technologies introduce un fármaco analgésico en el Reino UnidoLa empresa biofarmacéutica danesa Tetra Pharm Technologies se enorgullece de anunciar el lanzamiento de su medicamento recetado para aliviar el dolor, XATEPA®, en el Reino Unido. COPENHAGUE, Dinamarca, 19 de marzo de 2024 /PRNewswire/ -- Tras el exitoso lanzamiento de XATEPA® el año... Tetra Pharm Technologies introduces pain relieving drug in the United KingdomThe Danish biopharmaceutical company, Tetra Pharm Technologies, is proud to announce the launch of its pain-relieving prescription drug, XATEPA®, in the United Kingdom. COPENHAGEN, Denmark, March 19, 2024 /PRNewswire/ -- Following last year's successful launch of XATEPA® in Germany, the... TELUS Mental Health Index: Workers under 40 in the US are isolated and lonely resulting in reduced mental health and productivityWorkers who don't feel valued and respected by their colleagues or supported by their workplace are twice as likely to report that their mental health adversely affects their productivity compared to workers who feel valued and respected CHICAGO, March 19, 2024 /PRNewswire/ - Today, TELUS... Tetra Pharm Technologies introduces pain relieving drug in the United KingdomThe Danish biopharmaceutical company, Tetra Pharm Technologies, is proud to announce the launch of its pain-relieving prescription drug, XATEPA®, in the United Kingdom. COPENHAGEN, Denmark, March 19, 2024 /PRNewswire/ -- Following last year's successful launch of XATEPA® in Germany, the... BioArctic: Professor Lars Lannfelt, awarded Fondation Recherche Alzheimer's European Grand Prix for his contributions to science and treatment of Alzheimer's diseaseSTOCKHOLM, March 19, 2024 /PRNewswire/ -- BioArctic AB (publ) (STO: BIOA B) announced today that BioArctic's founder, Professor Lars Lannfelt, was awarded the European Grand Prix for his research on Alzheimer's disease at the anniversary gala for La Fondation Recherche Alzheimer in Paris... BioArctic: Professor Lars Lannfelt, awarded Fondation Recherche Alzheimer's European Grand Prix for his contributions to science and treatment of Alzheimer's diseaseSTOCKHOLM, March 19, 2024 /PRNewswire/ -- BioArctic AB (publ) (STO: BIOA B) announced today that BioArctic's founder, Professor Lars Lannfelt, was awarded the European Grand Prix for his research on Alzheimer's disease at the anniversary gala for La Fondation Recherche Alzheimer in Paris... Implantica wins another RefluxStop⢠public tender in Europe, this time in Spain with Hospital Universitario de GetafeVADUZ, Liechtenstein, March 19, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces the first-in-the-country public tender win for RefluxStop⢠at Hospital Universitario de Getafe, a public hospital in... Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat CancerTransaction includes actinium-based clinical-stage radioconjugate targeting PSMA for prostate cancer, pipeline of radioconjugates and state-of-the-art R&D and manufacturing facilities Fusion shareholders to receive $21.00 per share in cash at closing plus a non-transferrable contingent... Laboratory Centrifuge Market size to grow by USD 360.98 million from 2022-2027, Azer Scientific Inc., Accumax Lab Devices Pvt. Ltd. and Agilent Technologies Inc. are some of the leading companies, TechnavioNEW YORK, March 19, 2024 /PRNewswire/ -- The Laboratory Centrifuge Market size is projected to increase by USD 360.98 million, accelerating at a CAGR of 3.9% during the forecast period. Companies are implementing various strategies like forming partnerships, mergers, expanding into new... 2023 IQAir World Air Quality Report Finds Only 7 Countries Meet WHO PM2.5 Air Pollution GuidelineSTEINACH, Switzerland, March 19, 2024 /PRNewswire/ -- The 6th Annual World Air Quality Report reveals troubling details of the world's most polluted countries, territories, and regions in 2023. For this year's report, data from more than 30,000 air quality monitoring stations across 7,812... Cognizant to apply generative AI to enhance drug discovery for pharmaceutical clients with NVIDIA BioNeMoCognizant's AI and industry expertise, combined with the NVIDIA BioNeMo generative AI platform, create a strong foundation to improve outcomes in the healthcare and life sciences sectors TEANECK, N.J., March 19, 2024 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) is advancing the application of... Cognizant to apply generative AI to enhance drug discovery for pharmaceutical clients with NVIDIA BioNeMoCognizant's AI and industry expertise, combined with the NVIDIA BioNeMo generative AI platform, create a strong foundation to improve outcomes in the healthcare and life sciences sectors TEANECK, N.J., March 19, 2024 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) is advancing the application of... TELUS Mental Health Index: Alarming isolation and loneliness levels among young workers in the UKWorkers under 40 are 80 per cent more likely to lack trusted workplace relationships compared to workers over 50 impacting their mental health, physical wellbeing and productivity LONDON, March 19, 2024 /PRNewswire/ -- Today, TELUS Health released its TELUS Mental Health Index ("the... Asep Medical Holdings Inc. to Hold Significant Investor Information Webinar this Friday, March 22, 2024, at 4 pm ESTCLICK HERE TO REGISTER VANCOUVER, BC, March 18, 2024 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that it is holding an online webinar on March 22, 2024, at 4:00 pm EST to provide significant updates... Medical Composite Materials Market size to increase by USD 642.44 million between 2022 to 2027, 3M Co., ACP Composites Inc., Avient Corp. and more among key companies, TechnavioNEW YORK, March 18, 2024 /PRNewswire/ -- The Medical Composite Materials Market size is expected to grow by USD 642.44 million, accelerating at a CAGR of 9.02% during the forecast period. We provide a detailed analysis of 20 companies operating in the medical composite materials market... Breakthrough in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion: Release of Positive Results from Multicenter Phase III Global Clinical StudyThe world's first non-surgical cervical HSIL treatment validated by an international Phase III clinical study with proven efficacy; The response rate increased by 89.4% compared to the placebo control group, with a low incidence of adverse events; The China new drug application submission...
Press Releases by
|
|
|